Rapid Therapeutic Science Laboratories, Inc. (RTSL) Gross Profit (2020 - 2021)
Rapid Therapeutic Science Laboratories' Gross Profit history spans 2 years, with the latest figure at $60.0 for Q4 2021.
- For Q4 2021, Gross Profit changed N/A year-over-year to $60.0; the TTM value through Sep 2022 reached $60.0, down 99.95%, while the annual FY2021 figure was $334.0, 99.7% down from the prior year.
- Gross Profit for Q4 2021 was $60.0 at Rapid Therapeutic Science Laboratories, up from $50.0 in the prior quarter.
- Across five years, Gross Profit topped out at $110731.0 in Q2 2020 and bottomed at $50.0 in Q3 2021.